Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-25 @ 9:34 PM
Study NCT ID:
NCT03533751
Status:
COMPLETED
Last Update Posted:
2023-05-24
First Post:
2018-04-27
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Sponsor:
AnaptysBio, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-19
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-03
Completion Date Type:
ACTUAL
First Submit Date:
2018-04-27
First Submit QC Date:
None
Study First Post Date:
2018-05-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-04-26
Results First Submit QC Date:
None
Results First Post Date:
2023-05-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-26
Last Update Post Date:
2023-05-24
Last Update Post Date Type:
ACTUAL